Keryx Biopharmaceuticals to Webcast its Presentations at Two Investor Conferences in March 2017
February 23 2017 - 8:31AM
Keryx Biopharmaceuticals, Inc., (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
renal disease, today announced it will webcast its corporate
presentations at the following investor healthcare conferences:
Raymond James 38th Annual Institutional
Investors ConferencePresenter: Scott Holmes, SVP and Chief
Financial OfficerPresentation Date: Tuesday, March 7,
2017Presentation Time: 8:40 a.m. ET
37th Annual Cowen and Company Healthcare
ConferencePresenter: Greg Madison, President and Chief
Executive OfficerPresentation Date: Wednesday, March 8,
2017Presentation Time: 10:00 a.m. ET
Live audio webcasts of the presentations will be
accessible from Keryx’s website at http://investors.keryx.com
within the Investor Relations section under “webcasts and
presentations.” An archived version of the webcast will be
available for at least 15 days following the conclusion of the live
presentation.
About Keryx Biopharmaceuticals,
Inc. Keryx Biopharmaceuticals, Inc., with headquarters in
Boston, Massachusetts, is a commercial stage company focused on
bringing innovative medicines to people with renal disease. Keryx
developed and commercializes Auryxia® (ferric citrate) in the U.S.
Ferric citrate is marketed as Riona® by Keryx’s Japanese
partner, Japan Tobacco Inc. and Torii Pharmaceutical Co. Ltd. In
September 2015, the European Commission granted European market
authorization for Fexeric® (ferric citrate coordination
complex). Keryx has programs underway to leverage its
development and commercial infrastructure, including potentially
expanding the indication of Auryxia and in-licensing medicines
for renal disease. For more information about Keryx, please
visit www.keryx.com.
KERYX BIOPHARMACEUTICALS CONTACT:
Lora Pike
Senior Director, Investor Relations
T: 617-466-3511
lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Apr 2024 to May 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From May 2023 to May 2024